Photodermatology: Progress, problems and prospects

European Journal of Dermatology

Volumn 10, Issue 4, 2000, Pages 250-254

  Gasparro, Francis P ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cutaneous T cell lymphoma; PDT; Psoriasis; PUVA; Skin cancer; Ultraviolet

Indexed keywords

AMINOLEVULINIC ACID; DERMATOLOGICAL AGENT; PHOTOFRIN; PORPHYRIN;

ACTINIC KERATOSIS; CLINICAL TRIAL; DRUG METABOLISM; HUMAN; PHOTODYNAMIC THERAPY; PSORIASIS; PUVA; RADIATION DOSE; REVIEW; SKIN CANCER; SKIN LYMPHOMA; SUN EXPOSURE;

DERMATOLOGY; HUMANS; PHOTOBIOLOGY; PHOTOCHEMOTHERAPY; PHOTOPHERESIS; PHOTOSENSITIZING AGENTS; SKIN DISEASES; SUNSCREENING AGENTS; ULTRAVIOLET RAYS;

EID: 0034090453     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. 1. Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DJ. Sunlight and sunburn in human skin cancer: 53, apoptosis, and tumor promotion. J Invest Dermatol (Symposium Proceedings) 1996; 4: 136-42.
2. 2. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein EH Jr, Scott MP. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996; 272: 1668-71.
3. 3. McGregor JM, Young AR. Sunscreens, suntans and skin cancer. BMJ 1996; 312: 1621-2.
4. 3. a) Bissett DL, McBride JF, Hannon DP, Patrick LF. Time-dependent decrease in sunscreen protection against chronic photodamage in UVB-irradiated hairsless mouse skin. J Photochem Photobiol B Biol 1991; 9: 323-34.
5. b) Reeve VE, Bosnic M, Boehm-Wilcox C. Effect of ultraviolet (UV) radiation and UVB-absorbing sunscreen ingredients on 7,12 dimethylbenz(a)anthracene-initiated skin tumorigenesis in hairless mice. Photoderm Photoimmunol Photomed 1990; 7: 222-7.
6. c) Sunscreen Photobiology (Edited by FP Gasparro), Landes Press, Georgetown TX.
7. 4. Lowe NJ, Meyers DP, Wieder JM, Luftman D, Borget T, Lehman MD, Johnson AW, Scott IR. Low doses of repetitive ultraviolet A induce morphologic changes in human skin. J Invest Dermatol 1995; 105: 739-43.
8. 5. Wolf P, Kripke M. In: Sunscreen Photobiology. Gasparro FP, ed. Landes 1997. b) Halliday GM, Bestak R, Yuen KS, Cavanagh LL, Barnetson RS. UVA-induced immunosuppression. Mutat Res 1998; 422: 139-45.
9. 5. Wolf P, Kripke M. In: Sunscreen Photobiology. Gasparro FP, ed. Landes 1997. b) Halliday GM, Bestak R, Yuen KS, Cavanagh LL, Barnetson RS. UVA-induced immunosuppression. Mutat Res 1998; 422: 139-45.
10. 6. Davenport V, Morris JF, Chu AC. Immunologic protection afforded by sunscreens in vitro. J Invest Dermatol 1997; 108: 859-863. b) Gasparro FP. Photobiology 101. J Invest Dermatol 1998; 110: 183.
11. 6. Davenport V, Morris JF, Chu AC. Immunologic protection afforded by sunscreens in vitro. J Invest Dermatol 1997; 108: 859-863. b) Gasparro FP. Photobiology 101. J Invest Dermatol 1998; 110: 183.
12. 7. El-Ghorr AA, Norval M. The effect of UV-B irradiation on primary and secondary HSV-1 infections in interleukin-4 knockout mice. Arch Dermatol Res 1999; 291: 459-65.
13. 8. Young AR, Walker SL. Sunscreens: photoprotection of non-erythema endpoints relevant to skin cancer. Photodermatol Photoimmunol Photomed 1999; 15: 221-5.
14. 9. Damian DL, Barnetson RS, Halliday GM. Measurement of in vivo sunscreen immune protection factors in humans. Photochem Photobiol 1999; 70: 910-5.
15. 10. Weinstock MA. Sunscreens for melanoma prevention. Photodermatol Photoimmunol Photomed 1999; 15: 209-11.
16. 11. Autier P, Doré JF, Cattaruzza MS, Renard F, Luther H, Gentiloni-Silverj F, Zantedeschi E, et al. Sunscreen use, wearing clothes, and number of nevi in 6-to 7-year-old European children. J Natl Cancer Inst 1998; 90: 1873-80.
17. 12. Bigby M. Welcome to the "Evidence-based dermatology" section in the Archives of Dermatology. Arch Dermotol 1999; 135: 1512-3.
18. 13. Bigby M. The sunscreen and melanoma controversy. Arch Dermotol 1999; 135: 1526-7.
19. 14. Yound AR, Walker SL. Protoprotection form UVR-induced immunosuppression. In: Photoimmunology. Krutmann J, Elmets CA, eds. Blackwell Science, Cambridge MA, 1995: 22.
20. 15. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993; 329: 1147-51.
21. 16. Cohn BA. From sunlight to actinic keratosis to squamous cell carcinoma. J Am Acad Dermatol 2000; 42: 143-4.
22. 17. Stern RS, Thibodeau LA, Kleinerman RA, et al. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med 1979; 300: 809-13.
23. 18. Stem RS, Nichols KT and Väkevä LH for the PUVA follow-up study. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). N Engl J Med 1997; 336: 1041-5.
24. 19. Wang XM, McNiff JM, Klump V, Asgari M, Gasparro FP. An unexpected spectrum of p53 mutations from squamous cell carcinomas in patients treated with PUVA. Photochem Photobiol 1997; 66: 194-9.
25. 20. Gasparro FP. Extracorporeal Photochemotherapy : clinical aspects and the molecular basis for efficacy. RG Landes (Medical Intelligence Unit), 1994.
26. 21. Rook AH, Suchin KR, Kao DM, Yoo EK, Macey WH, DeNardo BJ Bromely PG, Geng Y, Junkins-Hopkins JM, Lessin SR. Photopheresis: clinical applications and mechanism of action. J Investig Dermatol Symp Proc 1999; 4: 85-90.
27. 22. Schwartz J, Gonzalez J, Palangio M, Klainer AS, Bisaccia E. Extracorporeal photochemotherapy in progressive systemic sclerosis: a follow-up study. Int J Dermatol 1997; 36: 380-5.
28. 23. Greinix HT, Volc-Platzer B, Rabitsch W, Gmeinhart B, Guevara-Pineda C, Kalhs P, Krutmann J, Honigsmann H, Ciovica M, Knobler RM. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood 1998; 92: 3098-104.
29. 24. Salerno CT, Park SJ, Kreykes NS, Kulick DM, Savik K, Hertz MI, Bolman RM 3rd. Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis. J Thorac Cardiovasc Surg 1999; 117: 1063-9.
30. 25. Fritsch C, Goerz G, Ruzicka T. Photodynamic therapy in dermatology. Arch Dermatol 1998; 134: 207-14.
31. 26. Mechcatie EFDA. Approves first drug-device combo for AKs. Skin & Allery News 2000.
32. 27. Woodburn KW, Fan Q, Kessel D, Luo Y, Young SW. Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrin. J Invest Dermatol 1998; 110: 746-51.
33. 28. Krutmann J. High-dose ultraviolet A1 (UVA1) phototherapy: does it work? Photodermatol Photoimmunol Photomed 1997; 13: 78-81.
34. 29. Stege H, Berneburg M, Humke S, Klammer M, Grewe M, Grether-Beck S, Boedeker R, Diepgen T, Dierks K, Goerz G, Ruzicka T, Krutmann J. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997; 36: 938-44.
35. 30. Plettenberg H, Stege H, Megahed M, Ruzicka T, Hosokawa Y, Tsuji T, Morita A, Krutmann J. Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 1999; 41: 47-50.
36. 31. Elkind MM, Han A, Chang-Liu CM. "Sunlight"-induced mammalian cell killing: a comparative study of ultraviolet and near-ultraviolet inactivation. Photochem Photobiol 1977; 27: 709-15.
37. 32. Woollons A, Kipp C, Young AR, Petit-Frere C, Arlett CF, Green MH, Clingen PH. The 0.8% ultraviolet B content of an ultraviolet A sunlamp induces 75% of cyclobutane pyrimidine dimers in human keratinocytes in vitro. Br J Dermatol 1999; 140: 1023-30.
38. 33. Coohill TP. Action spectroscopy: Ultraviolet radiation In: CRC Handbook of Photochemistry and Photobiology. Hoorspool WM, Song PS, eds. CRC Press, Boca Raton, FL, 1995: 1267-75.
39. 34. Drouin R, Therrien JP. UVB-induced cyclobutane pyrimidine dimer frequency correlates with skin cancer mutational hot spots in p53. Photochem Photobiol 1997; 66: 719-26.
40. 35. Learn DB, Beard J, Moloney JS. The ultraviolet C energy emitted from FS lamps contributes significantly to the induction of human erythema and murine ear edema. Photodermatol Photoimmunol Photomed 1993; 9: 147-53.
41. 36. Urbach F. Sources of radiant energy for medical uses. J Invest Dermatol 1959; 325: 167-9.
42. 37. Beasley DG, Beard J, Stanfield JW, Roberts LK. Evaluation of an economical sunlamp that emits a near solar UV power spectrum for conducting photoimmunological and sunscreen immune protection studies. Photochem Photobiol 1996; 64: 303-9.
43. 38. Douglas B Brown, Peritz AE, Mitchell DL, Chiarello S, Uitto J, Gasparro FP. Fluorescent sunlamps: an inappropriate substitute for sunlight (submitted).
44. 39. The year book on dermatology and dermatologic surgery. Thiers BH, ed. Mosby. NY NY, 1999, Table 19: 23.
45. 40. Gee S, Dufresne R. The assessment of seasonal affective disorder in the tanning bed population: a survey of tanning bed users. J Invest Dermatol 1999; 112: 519A.
46. 41. Rosenthal NE, Moul DE, Hellekson CJ, Oren DA, Frank A, Brainard GC, Murray MG, Wehr TA. A multicenter study of the light visor for seasonal affective disorder: no difference in efficacy found between two different intensities. Neuropsychopharmacology 1993; 8: 151-60.
47. 42. Gasparro FP. Photobiology. J Invest Dermatol 1998; 110: 183.